Area of research
Oncology · Molecular Biology
Research interest
Research interests include Cutaneous Melanoma Detection and Management, Cancer Immunotherapy and Biomarkers, Melanoma and MAPK Pathways, and CAR-T cell therapy research.
A Phase I, First-in-Human, Dose-Escalation, Expansion Trial of Cytokine-Encoding Synthetic mRNA Mixture Alone or with Cemiplimab in Advanced Solid Tumors
Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma
Long-Term Survival in Patients With Advanced Melanoma
Improving survival in advanced melanoma patients: a trend analysis from 2013 to 2021
Baseline tumor-infiltrating lymphocyte patterns and response to immune checkpoint inhibition in metastatic cutaneous melanoma
BRAF/MEK inhibitor rechallenge in advanced melanoma patients
Adjuvant treatment with anti‐ <scp>PD</scp> ‐1 in acral melanoma: A nationwide study
Abstract LB198: A first-in-human, open-label, multicenter study of intratumoral SAR441000 (mixture of cytokine encoding mRNAs), as monotherapy and in combination with cemiplimab in patients with advanced solid tumors
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma
Five-Year Analysis of Adjuvant Pembrolizumab or Placebo in Stage III Melanoma
Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma